News
USA: Preliminary results from the PANDOME study, published in The Journal of Clinical Endocrinology & Metabolism, have ...
For women with moderate-to-severe vasomotor symptoms associated with endocrine therapy for hormone receptor (HR)-positive ...
Highlights from the 2025 Global Equine Endocrinology Symposium included never-before-presented study results on insulin ...
Women who experience menopause before the age of 50-and especially before the age of 45-are more likely to develop fatty ...
Modern medical practices make widespread use of plastics, flame retardants, and perfluoroalkyl substances (PFAS), a group of ...
The following is a summary of “Oral semaglutide for the treatment of obesity: a retrospective real-world study,” published in ...
12d
MedPage Today on MSNEnd of Compounded Semaglutide; 464M Teens Will Have Obesity; GLP-1 Scripts SkyrocketResearchers said a single daytime sample of serum 17-hydroxyprogesterone and/or androstenedione is sufficient to monitor ...
A substantial number of US dementia cases could be eliminated by mitigating modifiable cardiometabolic risk factors.
6d
MedPage Today on MSNNon-Hormonal Drug Reduced Hot Flashes From Endocrine Therapy for Breast CancerCHICAGO -- The neurokinin-targeted agent elinzanetant significantly reduced the frequency of hot flashes among women ...
Telemedicine helped increase access to endocrinology care for adults with type 2 diabetes and atherosclerotic cardiovascular disease living in rural areas, but several disparities remain, researchers ...
4don MSN
The study, which was published in the journal eBioMedicine, linked a specific type of phthalate called ...
A new study, sponsored by AstraZeneca and presented at the American Society of Clinical Oncology (ASCO) annual meeting in ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results